KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Novartis Ag (NVS) Equity Ratio (2017 - 2025)

Novartis Ag's Equity Ratio history spans 9 years, with the latest figure at 0.42 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 2.61% year-over-year to 0.42; the TTM value through Dec 2025 reached 0.42, down 2.61%, while the annual FY2025 figure was 0.42, 2.61% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.42 at Novartis Ag, down from 0.43 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.51 in Q4 2021 and bottomed at 0.42 in Q4 2025.
  • The 5-year median for Equity Ratio is 0.47 (2023), against an average of 0.47.
  • The largest annual shift saw Equity Ratio soared 124165.74% in 2021 before it fell 7.9% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.51 in 2021, then fell by 1.69% to 0.51 in 2022, then dropped by 7.55% to 0.47 in 2023, then decreased by 7.9% to 0.43 in 2024, then fell by 2.61% to 0.42 in 2025.
  • Per Business Quant, the three most recent readings for NVS's Equity Ratio are 0.42 (Q4 2025), 0.43 (Q4 2024), and 0.47 (Q4 2023).